CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENTClinical Trial Collaboration and Supply Agreement • February 23rd, 2023 • Shattuck Labs, Inc. • Pharmaceutical preparations • New York
as of February 4, 2022 (the “Effective Date”), is by and between Shattuck Labs, Inc., a Delaware corporation (“Shattuck”), with a place of business at 500 W. 5th Street, Suite 1200, Austin, Texas 78701 (“Shattuck”) and ImmunoGen, Inc., having a place of business at 830 Winter Street, Waltham, MA 02451-1477, USA (“ImmunoGen”). Shattuck and ImmunoGen are each referred to herein individually as “Party” and collectively “Parties”.
